Literature DB >> 1474413

Lifetime data analysis of disease and aging by the Weibull probability distribution.

S Matsushita1, K Hagiwara, T Shiota, H Shimada, K Kuramoto, Y Toyokura.   

Abstract

We applied the Weibull distribution to the life-table and age-patterns of diseases in Japan. The life-table follows a composite Weibull distribution composed of initial failure and two stage wear-out failure periods. The extension of lifespan during the past century is manifested as increases in the scale parameters in all three periods and the shape parameters in the wear-out periods with female predominancy. The shape parameters of diseases show time-independent sex-dependent specific values. When consistent changes are observed, such as increases in the shape parameters of tuberculosis and pneumonia, legitimate causes such as prevention and repair at the societal and medical level are present. Cancer and arteriosclerosis share a common range of shape parameters suggesting analogous underlying biological processes. An analysis of the epidemiology of human aging and disease by the Weibull distribution discloses intrinsic properties of man as a biological organization as well as a societal presence.

Entities:  

Mesh:

Year:  1992        PMID: 1474413     DOI: 10.1016/0895-4356(92)90157-i

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  3 in total

1.  Determining the lifetime density function using a continuous approach.

Authors:  Rubén Román; Mercè Comas; Lorena Hoffmeister; Xavier Castells
Journal:  J Epidemiol Community Health       Date:  2007-10       Impact factor: 3.710

2.  Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects.

Authors:  Adam C Palmer; Peter K Sorger; Deborah Plana; Geoffrey Fell; Brian M Alexander
Journal:  Nat Commun       Date:  2022-02-15       Impact factor: 17.694

3.  The generational scalability of single-cell replicative aging.

Authors:  Ping Liu; Murat Acar
Journal:  Sci Adv       Date:  2018-01-31       Impact factor: 14.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.